Not Yet RecruitingNCT06131502
What is this study about?Researchers are evaluating MRI-guided focused ultrasound capsulotomy for OCD that has not sufficiently improved with medication and psychotherapy. The study examines both safety and symptom changes.
This study isn't recruiting yet.
Multiple locations, including Palo AltoOCDDevice studyAges 25–64
- Countries
- United States
- Sponsor
- Brigham and Women's Hospital
Not Yet RecruitingNCT07219667
Official study titleCommunity-Engaged Approach to Supporting South Asians With Type 2 Diabetes at Risk for Depression
This study isn't recruiting yet.
In New YorkDepressionBehavioural studyAges 18–75
- Countries
- United States
- Sponsor
- NYU Langone Health
Not Yet RecruitingNCT07200739
Official study titleDevelopment of Deep Learning Models for Detection of Neurodegenerative Diseases Using Speech - a Danish Language-based Artificial Intelligence Study (DetectAI)
This study isn't recruiting yet.
In RoskildeDepressionObservational studyAges 50+
- Countries
- Denmark
- Sponsor
- Zealand University Hospital
Not Yet RecruitingNCT06743321
Official study titleA Prospective Study of the Effectiveness of Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients
This study isn't recruiting yet.
In BeijingAnxietyBehavioural studyAges 18+
- Countries
- China
- Sponsor
- Peking Union Medical College Hospital
Not Yet RecruitingNCT07610785
Official study titleStandardized Adaptive Music Medicine for Suicidality
This study isn't recruiting yet.
In Palo AltoSuicidalityBehavioural studyAges 14–35
- Countries
- United States
- Sponsor
- Stanford University
Not Yet RecruitingACTRN12617000413325
Official study titleCaring for Carers: Examination of a manualised coping program (START) in reducing symptoms of depression, anxiety and carer burden in Australian carers of people with dementia.
This study isn't recruiting yet.
In AustraliaAnxiety, DepressionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- University of Newcastle
Not Yet RecruitingNCT07547384
Official study titleA Randomized, Open-label, Two-period, Crossover, Steady-state Bioequivalence Study of Aripiprazole for Injection Following Multiple Dosing in Patients With Schizophrenia
This study isn't recruiting yet.
Location not clearly listedSchizophreniaMedication studyAges 18–65
- Countries
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Not Yet RecruitingNCT06825507
Official study titleStepped Care Model of Lifestyle-based Mental Health Care for Depression: a Randomised Controlled Trial and Economic Evaluation
This study isn't recruiting yet.
Location not clearly listedDepressionBehavioural studyAges 18–64
- Countries
- Sponsor
- Chinese University of Hong Kong
Not Yet RecruitingACTRN12620001183976
Official study titleStepped Wedge Cluster Randomised Trial of the Impact of Social Prescribing of Forest Therapy on Quality of Life for Adults with Mental Illness
This study isn't recruiting yet.
In AustraliaPersonality disorders, Schizophrenia, ...Interventional studyAges 18+
- Countries
- Australia
- Sponsor
- Tamsin Thomas
Not Yet RecruitingNCT06699966
Official study titleStony Brook Medicine Anti-Inflammatory Trial
This study isn't recruiting yet.
Location not clearly listedDepressionMedication studyAges 18–65
- Countries
- Sponsor
- Stony Brook University
Not Yet RecruitingNCT07386483
Official study titleStrategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome (START GAAIMS): A Feasibility Study for a Prospective, Two-Arm, Randomised Controlled Trial to Evaluate the Effects of a Resistance Training Intervention on Body Composition and Metabolic Health in People With First-Episode Psychosis
This study isn't recruiting yet.
In DublinSchizophreniaInterventional studyAges 18–65
- Countries
- Ireland
- Sponsor
- University College Dublin
Not Yet RecruitingNCT07434973
Official study titleImPRoving OutcoMes in Individuals at Clinical High Risk fOr Psychosis Using Cannabidiol: a Double-blind, Randomised conTrollEd Trial
This study isn't recruiting yet.
Multiple locations, including ViennaSchizophreniaMedication studyAges 12–35
- Countries
- Canada, United Kingdom, Switzerland, + 7 others
- Sponsor
- University of Oxford (University)